UK Medical Courier Market Forecast to 2028 - COVID-19 Impact and Country Analysis By Product Type (Lab Specimens, Medical Supplies and Equipment, Blood and Organs, Medical Notes, and Others); Destination (Domestic and International); Service (Standard Ser

UK Medical Courier Market Forecast to 2028 - COVID-19 Impact and Country Analysis By Product Type (Lab Specimens, Medical Supplies and Equipment, Blood and Organs, Medical Notes, and Others); Destination (Domestic and International); Service (Standard Services and Rush and On-demand Services), and End User (Hospitals and Clinics, Diagnostics Labs, Pharmaceutical and Biotechnology Companies, Blood and Tissue Banks, Pharmacies, In Home Support, and Others)

The medical courier market size is expected to reach US$ 505.27 million in 2028 from US$ 373.92 million in 2022; it is estimated to record a CAGR of 5.2% from 2023 to 2028.

Rising Prevalence of Chronic Diseases

According to an article by BMC Public Health, the most typical conditions across the UK were chronic kidney disease (7.2%), diabetes mellitus (7.1%), asthma (6.5%), and chronic heart disease (4.5%). The prevalence of each condition varied nationally. Multimorbidity was common, ranging from 6.2% in England to 7.9% in Northern Ireland: 7.1% across the UK. Also, as per the July 2021 report of the British Heart Foundation, about 7.6 million people in the UK were suffering from cardiovascular diseases, of which 4 million were males and 3.6 million were females. Also, the rising diabetic population of the country will have a positive impact on the market. As per the report of Diabetes UK, published in February 2020, about 3.9 million people in the UK were diagnosed with diabetes in 2019, with 3.3 million people in England, of these, 90% had type 2 diabetes. According to the stats by the Royal College of Pathologists Registered Charity in England and Wales, it is estimated that 5 million people in the UK will have diabetes by 2025.

Thus, the increasing cases of diabetes and other chronic diseases in the UK is simultaneously propelling the demand for insulin and other medical supplies and positively influencing the UK medical courier market growth.

Market Opportunity

Growing Strategic Initiatives

Several giants operating in the industry are taking strategic initiatives such as mergers and acquisitions, partnerships and collaborations, as well as unveiling new products to expand their foothold, support the end users in faster delivery of medical supplies, offer value-based care, and maintain a competitive edge in the market.

For instance, a consortium led by AGS Airports launched its next phase—Care and Equity – Healthcare Logistics UAS Scotland (CAELUS)—in partnership with NHS Scotland in September 2022. It secured US$ 12.56 million in funding from the Future Flight Challenge at UK Research and Innovation in August 2022. CAELUS brings together 16 partners, including Atkins, the University of Strathclyde, NATS, and NHS Scotland. Together they are work to deliver essential medicines, blood, and other medical supplies throughout Scotland, including remote communities, through the first national drone network to transport. By securing US$ 1.86 million in January 2020, the CAELUS consortium designed drone landing stations for NHS sites across Scotland and developed a virtual model (digital twin) of the proposed delivery network, which connects hospitals, pathology laboratories, distribution centers, and GP surgeries across Scotland. NHS Scotland has said it will bring its Once for Scotland approach to the project. Further, the second phase will involve live flight trials and remove remaining barriers to safely use drones at scale within Scotland's airspace.

The UK medical courier market, based on product type, is segmented into lab specimens, medical supplies and equipment, blood and organs, medical notes, and others. The UK medical courier market, in terms of destination, is fragmented into domestic and international. On the basis of service type, is bifurcated into standard services and rush and on-demand services. The UK medical courier market, based on end user, is segmented into hospitals and clinics, diagnostic labs, pharmaceutical and biotechnology companies, blood and tissue banks, in-home support, and others.

Key players in the medical courier market secure growth through various strategies. In October 2022, Med Logistics Group Ltd partnered with Skyfarer and University Hospitals Coventry and Warwickshire (UHCW) NHS Trust to conduct a trial for Beyond Visual Line of Sight (BVLOS) drone in the UK. The drone is first-of-its-kind, and the trial was completed under secure CAA-approved airspace called The Medical Logistics UK Corridor.

The National Health Service, National Health Services Blood and Transplant, Essex Partnership University NHS Foundation Trust, British Medical Association, and Department of Health and Social Care are a few key primary and secondary sources referred to while preparing the report on the medical courier market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the UK medical courier market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the UK medical courier market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.